Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Boehringer Ingelheim
Merck
Moodys
McKinsey

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TAZAROTENE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Tazarotene

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed Allergan Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed Jefferson Medical College of Thomas Jefferson University Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed Milton S. Hershey Medical Center Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Tazarotene

Condition Name

Condition Name for Tazarotene
Intervention Trials
Acne Vulgaris 20
Plaque Psoriasis 4
Psoriasis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Tazarotene
Intervention Trials
Acne Vulgaris 20
Psoriasis 9
Basal Cell Nevus Syndrome 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Tazarotene

Trials by Country

Trials by Country for Tazarotene
Location Trials
United States 113
Canada 6
India 2
Belize 1
Germany 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Tazarotene
Location Trials
California 11
Florida 10
Texas 8
Pennsylvania 8
New York 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Tazarotene

Clinical Trial Phase

Clinical Trial Phase for Tazarotene
Clinical Trial Phase Trials
Phase 4 8
Phase 3 8
Phase 2 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Tazarotene
Clinical Trial Phase Trials
Completed 24
Recruiting 5
Terminated 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Tazarotene

Sponsor Name

Sponsor Name for Tazarotene
Sponsor Trials
Stiefel, a GSK Company 8
GlaxoSmithKline 8
Allergan 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Tazarotene
Sponsor Trials
Industry 38
Other 20
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Boehringer Ingelheim
McKesson
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.